AUROLIFE PHARMA LLC FDA Approval ANDA 088725

ANDA 088725

AUROLIFE PHARMA LLC

FDA Drug Application

Application #088725

Application Sponsors

ANDA 088725AUROLIFE PHARMA LLC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL100MG0CHLORPROPAMIDECHLORPROPAMIDE

FDA Submissions

ORIG1AP1984-08-31
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1985-01-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1986-01-15
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1986-08-07
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1986-08-07
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1986-08-07
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1986-08-07
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1994-12-30
BIOEQUIV; BioequivalenceSUPPL15AP1989-02-15
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1999-12-14

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL14Null0
SUPPL15Null0
SUPPL17Null0

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88725
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLORPROPAMIDE","activeIngredients":"CHLORPROPAMIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CHLORPROPAMIDE","submission":"CHLORPROPAMIDE","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.